Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 1.10.2024MEDOCHEMIE Ltd. (MOE)65114MEDOCLAV 1,2 g (plo ijf 100x1,2 g (liek.inj.skl.))30.9.2024R
 1.10.2024MEDOCHEMIE Ltd. (MOE)6625DMEDOVIR 250 mg prášok na infúzny roztok (plv ifo 5x250 mg (liek.inj.skl.))30.9.2024O
 1.10.2024MEDOCHEMIE Ltd. (MOE)67030MEDOFLUCON 50 mg (cps dur 7x50 mg (blis.PVC/Al))30.9.2024R
 1.10.2024MEDOCHEMIE Ltd. (MOE)67512MEDOCRIPTINE (tbl 30x2,5 mg (blis.PVC/Al))30.9.2024R
 1.10.2024MEDOCHEMIE Ltd. (MOE)67517MEDOCIPRIN 250 mg (tbl flm 10x250 mg (blis.PVC/Al))30.9.2024R
 1.10.2024MEDOCHEMIE Ltd. (MOE)67525ANARGIL 100 mg (cps dur 100x100 mg (blis.PVC/Al))30.9.2024R
 1.10.2024MEDOCHEMIE Ltd. (MOE)67550ALMIRAL GEL (gel 1x250 g (obal plast.))30.9.2024O
 1.10.2024MEDOCHEMIE Ltd. (MOE)67558MABRON (sol inj 5x2 ml/100 mg (amp.skl.hnedá))30.9.2024R
 1.10.2024MEDOCHEMIE Ltd. (MOE)67562Dapril 10 mg (tbl 30x10 mg (blis.PVC/PVDC/Al))30.9.2024O
 1.10.2024MEDOCHEMIE Ltd. (MOE)8859AMEDOSPIR 25 mg (tbl 100x25 mg (blis.PVC/Al))30.9.2024O
 1.10.2024MEDOCHEMIE Ltd. (MOE)93330MABRON RETARD 100 (tbl plg 30x100 mg (blis.Al/PVC))30.9.2024O
 1.10.2024MEDOCHEMIE Ltd. (MOE)93336Mabron Retard 200 (tbl plg 30x200 mg (blis.Al/PVC))30.9.2024R
 1.10.2024MEDOCHEMIE Ltd. (MOE)96084MEDOFLUCON 150 mg (cps dur 1x150 mg (blis.PVC/Al))30.9.2024R
 1.10.2024Opella Healthcare Slovakia s.r.o. (OPL)24938Essentiale 300 mg (cps dur 100x300 mg (blis.Al/PVC))1.10.2024Z
 1.10.2024Janssen Biologics B.V. (JAN-NL)02578Remicade 100 mg prášok na prípravu infúzneho koncentrátu (plc ifc 1x100 mg (liek.inj.skl.))1.10.2024R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)